Actemra 162 MG/0.9 ML syringe 0.9ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9MY1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,464
Award facts
- Contract value 100% obligated
- $14,463.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded January 26, 2026, to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) by the Defense Logistics Agency, provides for the supply of Actemra 162 mg/0.9 mL syringes valued at $14,463.51, with completion targeted for January 27, 2026. The award utilizes a firm fixed-price structure with no set-aside designation, indicating competitive selection. The contract will be performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate operations as a major pharmaceutical distributor serving federal medical procurement needs.
This delivery order operates under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, an expansive $999,999,999 vehicle extending through December 2026 that serves as the primary mechanism for supplying pharmaceutical products and medical supplies to military healthcare systems globally. The IDC encompasses a comprehensive range of medications, vaccines, medical devices, and specialty pharmaceuticals across multiple therapeutic domains. AmerisourceBergen's extensive federal contracting history demonstrates its established capability to efficiently fulfill government requirements for essential pharmaceutical commodities supporting military treatment facilities, the Defense Health Agency, and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F9MY1?
SPE2DR26F9MY1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F9MY1 worth?
The government has obligated $14,464 on SPE2DR26F9MY1.
Is contract SPE2DR26F9MY1 an order under another contract?
Yes. SPE2DR26F9MY1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9MY1 competed?
The extent of competition for SPE2DR26F9MY1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award